Jump to navigation
Testing rates are still way below where they should be.
The urine test for Mycoplasma genitalium will both identify the pathogen and show whether it will...
Should Australia follow the UK's lead?
New data shows the current state of play.
A special and punitive focus to STIs risks further entrenching stigma, writes Denton Callander.
Vaginal orgasm is clouded in myths and misunderstanding. This article examines the evidence.
It can start with a simple question.
Researchers say it's a cheap, easy-to-use and effective agent.
8 questions for the Kirby Institute's Professor Basil Donovan.
It isn't usually considered in transmission.
More and more doctors are fielding inquiries.
Is a gonorrhoea vaccine on the cards?
The message is that different pills affect patients to different degrees.
Resistant strains surged in the first three months of 2016.
Only 1000 prescriptions have been filled in its first two months on the market.
Optimal treatment of this newly identified STI remains unclear.
As the mercury rises, so does sex drive, an Australian study suggests.
Rising issue dwarfs the threat of drug-resistant gonorrhoea.
National trial has doubled screening rates but failed to reduce rates of the infection.
Most men are totally happy with the appearance of their partner’s genitalia, an Australian study suggests.
Australian Doctor Group (ADG) is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.